Diabetes risk detection study in Primary Care according to FINDRISC questionnaire in the Municipality of Gral. Pueyrredón (Dr. Diap study)
DOI:
https://doi.org/10.47196/diab.v50i3.29Keywords:
type 2 diabetes mellitus, risk factors, primary careAbstract
Objective: to determine the size of the population at risk of developing diabetes mellitus in the population of the municipality of Gral. Pueyrredón who go-attend to Health Centers for Primary Care.
Materials y methods: observational study to determine the risk of developing DM2, through an interview where questions were asked about the 8 questions Questionnaire FINDRISC.
Results: the study sample consisted of 2.784 patients, 54% were women. Age was grouped in less than 45 years old 47.5% (1.323) from 45 to 54 years old 20.9% (582) from 55 to 64 years old 18.3% (510), and over 64 years old 13.2% (368). 20% of the population has a score of the risk scale questionnaire FINDRISC greater than or equal to 15, high risk to very high risk of developing diabetes in the next 10 years. The 43,38% showed a BMI >30 and 25.97% was currently receiving medication for high blood pressure. The 55.37% reported low physical activity, 50.79% do not eat vegetables and fruits on a daily basis and 17.98% declared high blood glucose. The variables most commonly associated with a risk score >15 were: sedentary lifestyle (80.9%), waist >102/88 (65.7/77.2%), history of hyperglycemia (64.0%), unhealthy diet (61.9%) and BMI>30 (61.8%). The risk >15 according to BMI was: BMI <25, 2.3%, BMI 25-30 16.9%, and BMI >30 45.4%.
Conclusions: 20% of the surveyed population is at high risk for diabetes. One of every 2 or 3 non-diabetic patients attending to a primary care center have a FINDRISC >15. This diabetes risk scale is a simple, inexpensive tool, making quick, noninvasive and safe exploration to identify individuals at high risk of developing type 2 diabetes. It also can be used to identify undetected DM2 and risk factors for cardio vascular disease.
References
Atlas de la Diabetes de la FID, 6° Ed. Actualización 2014; Diabetes Voice: Vol. 59- Diciembre de 2014.
Tercera Encuesta Nacional de Factores de Riesgo para Enfermedades No Transmisibles (ENFR). Oct/Dic de 2013.
Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, et al. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006; 29:1872-7.
Lindstrom J, Toumilehto J. A practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26:725-31.
Costa B, Barrio F, Bolívar B, Castell C. Prevención primaria de la diabetes tipo 2 en Cataluña mediante la intervención sobre el estilo de vida en personas de alto riesgo. MedClin (Barc) 2007; 128:699-704.
ADA. Economic Costs of Diabetes in the US in 2012. Diabetes Care 2013; Vol. 36, April 2013,1033-1046.
Simmons RK, Unwin N, Griffin SJ. International Diabetes Federation: an update of the evidence concerning the prevention of type 2 diabetes. Diabetes Res Clin Pract 2010 Feb; 87(2):143-9.
Absetz P, Valve R, Oldemburg B, Heinonen H, et al. Type 2 diabetes prevention in the “Real Word”. One-year results of the GOAL Implementation Trial. Diabetes Care 2007; 30:2465-2470.
Type 2 Diabetes Risk Test: American Diabetes Association®. Disponible en: www.diabetes.org/are-you-at-risk/diabetes-risk-test.
Eriksson KF, Lindgärde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study. Diabetologia 1991 Dec; 34(12):891-8.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Bennett PH, Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Aunola S, Cepaitis Z, Moltchanov V, Hakumäki M, Mannelin M, Martikkala V, Sundvall J, Uusitupa M. For the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 may; 344:1343-1350.
Diabetes Prevention Program Research Grup. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin”. N Engl J Med 2002; Vol. 346, N°6.
Chiasson JL, Gomis R, Hanefeld M, Josse RG, Karasik A, Laakso M, the STOP-NIDDOM Research Group. An international study on the efficacy of an α-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance; rationale, design, and preliminaresceening data. Diabetes Care 1998; 21,1720-1725.
De Fonzo RA, Tripathy D, et al. Pioglitazone for diabetes prevention in impaired glucose tolerance (ACT NOW Study). N Engl J Med 2011; 364:1104-15.
Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. Diabetes Care 2004; 27:155-161.
The DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N Engl J Med 2006 oct; 355:1551-1562.
Schmiedel K, Mayr A, Fiebler C, Schlager H, Friedland K. Effects of the lifestyle intervention Program GLICEMIA in people at risk for type 2 diabetes: a cluster-randomized controlled trial. Diabetes Care 2015; 38:937-939. DOI: 10.2337/dc14-2206.
Saaristo T, Peltonen M, Lindström J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic síndrome. Diabetes Vasc Dis Res 2005; 2:67-72.
Alberti KG, et al. Diabetes UK. Diabetic Medicine 2007; 24, 451-463.
Hernández-Hernández R, Silva H, Velasco M, et al. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study. J Hypertens 2010; 28:24-34.
Nigro D, Vergottini JC, Kushnir E, y col. Epidemiología de la hipertensión arterial en la Ciudad de Córdoba. Rev Fed Arg Cardiol 1999; 28:69-75.
Luquez H, Madoery RJ, de Loredo L, y col. Prevalencia de hipertensión arterial y factores de riesgo asociados. Estudio Dean Funes (Provincia de Córdoba, Argentina) Rev Fed Arg Cardiol 1999; 28:93-104.
National Cholesterol Education Program. ATP III Guidelines. Disponible en: http://www.nhlbi.nih.gov/files/docs/guidelines/atglance.pdf.
Dunkley AJ, Bodicoat DH, Greaves CJ, Russell C, Yates T, Davies MJ, Khunti K. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations. A systematic review and meta-analysis. Diabetes Care 2014; 37:922-933. DOI: 10.2337/dc13-2195.
Lindström J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care december 2003; 26:3230-3236. Doi:10.2337.
Alimentación saludable. Plan Argentina Saludable. Disponible en: www.msal.gov.ar/argentina-saludable/lineas/alimentacion.html.
Guariguata L. Diabetes Voice (57) Diciembre 2012.
Block G, Azar KMJ, Block TJ, Romanelli RJ, Carpenter H, Hopkins D, Palaniappan L, Block CH. A fully automated diabetes prevention program, alive-PD: Program Design and Randomized Controlled Trial Protocol. JMIR Res Protoc 2015; 4(1):e3.
Chamany S, Walker EA, Schechter CB, Gonzalez JS, Davis NJ, Ortega FM, Carrasco J, Basch CE, Silver LD. Telephone intervention to improve diabetes control: a randomized trial in the New York City. Am J Prev Med. 2015 Dec; 49(6):832-41.
Coghlan E, Quero B, y col. Prevalencia de hipertensión arterial en una comunidad aborigen del norte argentino. Medicina (B Aires) 2005; 65:108-112.
Bianchi ME, Farias EF, Bolano J, Massari PU. Epidemiology of renal and cardiovascular risk factors in Tobas aborigines. Ren Fail 2006; 28:665-670.
Gamarra J, Quintana M, y col. Prevalencia de hipertensión arterial en una comunidad aborigen Qom de la ciudad de Formosa. Revista de Posgrado de la VI Cátedra de Medicina diciembre 2011; N° 210:5-6.
Ingaramo RA, Williams D, y col. Prevalence and characteristics of high blood presure in native Americans of Chubut, Argentina. Resumen del 2010 Annual Scientific Meeting and Exposition, American Society of Hypertension, Nueva York, 1 a 4 de mayo de 2010. PO-286.
Sección 4: Guía para las mediciones físicas. Disponible en: Step2...www.who.int/chp/steps/Parte3_Seccion4.pdf.
Azue K, Oshiro T. Efficacy of lifestyle education to prevent type 2 diabetes. A meta-analysis of randomized controlled trials. Diabetes Care 2005; 28:2780-2786.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
